Loading...
Header Logo
Keywords
Last Name
Institution

SHIVA GUPTA

TitleAssistant Professor
InstitutionMD Anderson
DepartmentDiagnostic Radiology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Burgenske DM, Yang J, Decker PA, Kollmeyer TM, Kosel ML, Mladek AC, Caron AA, Vaubel RA, Gupta SK, Kitange GJ, Sicotte H, Youland RS, Remonde D, Voss JS, Fritcher EGB, Kolsky KL, Ida CM, Meyer FB, Lachance DH, Parney IJ, Kipp BR, Giannini C, Sulman EP, Jenkins RB, Eckel-Passow JE, Sarkaria JN. Molecular Profiling of Long-Term IDH-wildtype Glioblastoma Survivors. Neuro Oncol. 2019 Jul 26. PMID: 31346613.
      View in: PubMed
    2. Li W, Gupta SK, Han W, Kundson RA, Nelson S, Knutson D, Greipp PT, Elsawa SF, Sotomayor EM, Gupta M. Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors. J Hematol Oncol. 2019 Jul 09; 12(1):73. PMID: 31288832.
      View in: PubMed
    3. Welby JP, Kaptzan T, Wohl A, Peterson TE, Raghunathan A, Brown DA, Gupta SK, Zhang L, Daniels DJ. Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas. Front Oncol. 2019; 9:92. PMID: 30873381.
      View in: PubMed
    4. Gupta SK, Smith EJ, Mladek AC, Tian S, Decker PA, Kizilbash SH, Kitange GJ, Sarkaria JN. PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular Heterogeneity. Front Oncol. 2018; 8:670. PMID: 30723695.
      View in: PubMed
    5. Jensen CT, Wagner-Bartak NA, Vu LN, Liu X, Raval B, Martinez D, Wei W, Cheng Y, Samei E, Gupta S. Detection of Colorectal Hepatic Metastases Is Superior at Standard Radiation Dose CT versus Reduced Dose CT. Radiology. 2019 Feb; 290(2):400-409. PMID: 30480489.
      View in: PubMed
    6. Randall EC, Emdal KB, Laramy JK, Kim M, Roos A, Calligaris D, Regan MS, Gupta SK, Mladek AC, Carlson BL, Johnson AJ, Lu FK, Xie XS, Joughin BA, Reddy RJ, Peng S, Abdelmoula WM, Jackson PR, Kolluri A, Kellersberger KA, Agar JN, Lauffenburger DA, Swanson KR, Tran NL, Elmquist WF, White FM, Sarkaria JN, Agar NYR. Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma. Nat Commun. 2018 11 21; 9(1):4904. PMID: 30464169.
      View in: PubMed
    7. Cox VL, Saeed Bamashmos AA, Foo WC, Gupta S, Yedururi S, Garg N, Kang HC. Lynch Syndrome: Genomics Update and Imaging Review. Radiographics. 2018 Mar-Apr; 38(2):483-499. PMID: 29528821.
      View in: PubMed
    8. Kang HC, Gupta S, Wei W, Lu L, Matrana MR, Tannir NM, Choi H. Alternative Response Criteria and Clinical Risk Factors for Assessing Tumor Response in Patients With Metastatic Renal Cell Carcinoma Who Are Receiving Salvage Therapy. AJR Am J Roentgenol. 2017 Dec; 209(6):1278-1284. PMID: 29064751.
      View in: PubMed
    9. Gupta S, Kang HC, Ganeshan D, Morani A, Gautam R, Choyke PL, Kundra V. The ABCs of BHD: An In-Depth Review of Birt-Hogg-Dubé Syndrome. AJR Am J Roentgenol. 2017 Dec; 209(6):1291-1296. PMID: 28981362.
      View in: PubMed
    10. Kizilbash SH, Gupta SK, Chang K, Kawashima R, Parrish KE, Carlson BL, Bakken KK, Mladek AC, Schroeder MA, Decker PA, Kitange GJ, Shen Y, Feng Y, Protter AA, Elmquist WF, Sarkaria JN. Restricted Delivery of Talazoparib Across the Blood-Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma. Mol Cancer Ther. 2017 Dec; 16(12):2735-2746. PMID: 28947502.
      View in: PubMed
    11. Laramy JK, Kim M, Gupta SK, Parrish KE, Zhang S, Bakken KK, Carlson BL, Mladek AC, Ma DJ, Sarkaria JN, Elmquist WF. Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of Glioblastoma. J Pharmacol Exp Ther. 2017 11; 363(2):136-147. PMID: 28847917.
      View in: PubMed
    12. Hu G, Gupta SK, Troska TP, Nair A, Gupta M. Long non-coding RNA profile in mantle cell lymphoma identifies a functional lncRNA ROR1-AS1 associated with EZH2/PRC2 complex. Oncotarget. 2017 Oct 06; 8(46):80223-80234. PMID: 29113297.
      View in: PubMed
    13. Mamo T, Mladek AC, Shogren KL, Gustafson C, Gupta SK, Riester SM, Maran A, Galindo M, van Wijnen AJ, Sarkaria JN, Yaszemski MJ. Inhibiting DNA-PKCS radiosensitizes human osteosarcoma cells. Biochem Biophys Res Commun. 2017 04 29; 486(2):307-313. PMID: 28300555.
      View in: PubMed
    14. Nagel ZD, Kitange GJ, Gupta SK, Joughin BA, Chaim IA, Mazzucato P, Lauffenburger DA, Sarkaria JN, Samson LD. DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma Multiforme. Cancer Res. 2017 01 01; 77(1):198-206. PMID: 27793847.
      View in: PubMed
    15. Gupta S, Sonagere M, Formal CS, Kucer B. Poster 18 Buried Bumper Syndrome in a Traumatic Spinal Cord Injury Patient: A Case Report. PM R. 2016 Sep; 8(9S):S166-S167. PMID: 27672786.
      View in: PubMed
    16. Gupta S, Wagner-Bartak N, Jensen CT, Hui A, Wei W, Lertdilok P, Qayyum A, Tamm EP. Dual-energy CT of pancreatic adenocarcinoma: reproducibility of primary tumor measurements and assessment of tumor conspicuity and margin sharpness. Abdom Radiol (NY). 2016 07; 41(7):1317-24. PMID: 26956643.
      View in: PubMed
    17. Gupta SK, Kizilbash SH, Carlson BL, Mladek AC, Boakye-Agyeman F, Bakken KK, Pokorny JL, Schroeder MA, Decker PA, Cen L, Eckel-Passow JE, Sarkar G, Ballman KV, Reid JM, Jenkins RB, Verhaak RG, Sulman EP, Kitange GJ, Sarkaria JN. Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma. J Natl Cancer Inst. 2016 May; 108(5). PMID: 26615020.
      View in: PubMed
    18. Gupta S, Kang HC, Ganeshan DM, Bathala TK, Kundra V. Diagnostic approach to hereditary renal cell carcinoma. AJR Am J Roentgenol. 2015 May; 204(5):1031-41. PMID: 25905938.
      View in: PubMed
    19. Morani AC, Vicens RA, Wei W, Gupta S, Vikram R, Balachandran A, Reed BJ, Ma J, Qayyum A, Szklaruk J. CAIPIRINHA-VIBE and GRAPPA-VIBE for liver MRI at 1.5 T: a comparative in vivo patient study. J Comput Assist Tomogr. 2015 Mar-Apr; 39(2):263-9. PMID: 25635931.
      View in: PubMed
    20. Pokorny JL, Calligaris D, Gupta SK, Iyekegbe DO, Mueller D, Bakken KK, Carlson BL, Schroeder MA, Evans DL, Lou Z, Decker PA, Eckel-Passow JE, Pucci V, Ma B, Shumway SD, Elmquist WF, Agar NY, Sarkaria JN. The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma. Clin Cancer Res. 2015 Apr 15; 21(8):1916-24. PMID: 25609063.
      View in: PubMed
    21. Grams MP, Wilson ZC, Sio TT, Beltran CJ, Tryggestad EJ, Gupta SK, Blackwell CR, McCollough KP, Sarkaria JN, Furutani KM. Design and characterization of an economical (192)Ir hemi-brain small animal irradiator. Int J Radiat Biol. 2014 Oct; 90(10):936-942. PMID: 24844370.
      View in: PubMed
    22. Gupta SK, Mladek AC, Carlson BL, Boakye-Agyeman F, Bakken KK, Kizilbash SH, Schroeder MA, Reid J, Sarkaria JN. Discordant in vitro and in vivo chemopotentiating effects of the PARP inhibitor veliparib in temozolomide-sensitive versus -resistant glioblastoma multiforme xenografts. Clin Cancer Res. 2014 Jul 15; 20(14):3730-41. PMID: 24838527.
      View in: PubMed
    23. Guglielmo FF, Mitchell DG, Gupta S. Gadolinium contrast agent selection and optimal use for body MR imaging. Radiol Clin North Am. 2014 Jul; 52(4):637-56. PMID: 24889165.
      View in: PubMed
    24. Ganeshan D, Morani A, Ladha H, Bathala T, Kang H, Gupta S, Lalwani N, Kundra V. Staging, surveillance, and evaluation of response to therapy in renal cell carcinoma: role of MDCT. Abdom Imaging. 2014 Feb; 39(1):66-85. PMID: 24077815.
      View in: PubMed
    25. Andrianifahanana M, Wilkes MC, Gupta SK, Rahimi RA, Repellin CE, Edens M, Wittenberger J, Yin X, Maidl E, Becker J, Leof EB. Profibrotic TGFß responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases. FASEB J. 2013 Nov; 27(11):4444-54. PMID: 23913859.
      View in: PubMed
    26. Halpern EJ, Gupta S, Halpern DJ, Wiener DH, Owen AN. Characterization and normal measurements of the left ventricular outflow tract by ECG-gated cardiac CT: implications for disorders of the outflow tract and aortic valve. Acad Radiol. 2012 Oct; 19(10):1252-9. PMID: 22854005.
      View in: PubMed
    27. Kitange GJ, Mladek AC, Carlson BL, Schroeder MA, Pokorny JL, Cen L, Decker PA, Wu W, Lomberk GA, Gupta SK, Urrutia RA, Sarkaria JN. Inhibition of histone deacetylation potentiates the evolution of acquired temozolomide resistance linked to MGMT upregulation in glioblastoma xenografts. Clin Cancer Res. 2012 Aug 01; 18(15):4070-9. PMID: 22675172.
      View in: PubMed
    28. Hong M, Wilkes MC, Penheiter SG, Gupta SK, Edens M, Leof EB. Non-Smad transforming growth factor-ß signaling regulated by focal adhesion kinase binding the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem. 2011 May 20; 286(20):17841-50. PMID: 21454615.
      View in: PubMed
    29. Oommen S, Gupta SK, Vlahakis NE. Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site. J Biol Chem. 2011 Jan 14; 286(2):1083-92. PMID: 21071450.
      View in: PubMed
    30. Gupta SK, Vlahakis NE. Integrin alpha9beta1: Unique signaling pathways reveal diverse biological roles. Cell Adh Migr. 2010 Apr-Jun; 4(2):194-8. PMID: 20179422.
      View in: PubMed
    31. Seyama K, Mitani K, Kumasaka T, Gupta SK, Oommen S, Liu G, Ryu JH, Vlahakis NE. Lymphangioleiomyoma cells and lymphatic endothelial cells: expression of VEGFR-3 in lymphangioleiomyoma cell clusters. Am J Pathol. 2010 Apr; 176(4):2051-2; author reply 2052-4. PMID: 20203284.
      View in: PubMed
    32. Issaka RB, Oommen S, Gupta SK, Liu G, Myers JL, Ryu JH, Vlahakis NE. Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cells through autocrine crosstalk with endothelium. Am J Pathol. 2009 Oct; 175(4):1410-20. PMID: 19717640.
      View in: PubMed
    33. Gupta SK, Vlahakis NE. Integrin alpha9beta1 mediates enhanced cell migration through nitric oxide synthase activity regulated by Src tyrosine kinase. J Cell Sci. 2009 Jun 15; 122(Pt 12):2043-54. PMID: 19470583.
      View in: PubMed
    34. Aragona M, Onesti E, Tomassini V, Conte A, Gupta S, Gilio F, Pantano P, Pozzilli C, Inghilleri M. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study. Clin Neuropharmacol. 2009 Jan-Feb; 32(1):41-7. PMID: 18978501.
      View in: PubMed
    35. Chiu AW, Richert N, Ehrmantraut M, Ohayon J, Gupta S, Bomboi G, Gaindh D, Cantor FK, Frank JA, McFarland HF, Bagnato F. Heterogeneity in response to interferon beta in patients with multiple sclerosis: a 3-year monthly imaging study. Arch Neurol. 2009 Jan; 66(1):39-43. PMID: 19001157.
      View in: PubMed
    36. Di Rezze S, Gupta S, Durastanti V, Millefiorini E, Pozzilli C, Bagnato F. An exploratory study on interferon beta dose effect in reducing size of enhancing lesions in multiple sclerosis. Mult Scler. 2007 Apr; 13(3):343-7. PMID: 17439903.
      View in: PubMed
    37. Bagnato F, Butman JA, Gupta S, Calabrese M, Pezawas L, Ohayon JM, Tovar-Moll F, Riva M, Cao MM, Talagala SL, McFarland HF. In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis. AJNR Am J Neuroradiol. 2006 Nov-Dec; 27(10):2161-7. PMID: 17110688.
      View in: PubMed
    38. Griffith C, Bagnato F, Gupta S, Calabrese A, Oh U, Chiu A, Ohayon JM, McAuliffe MJ, Tasciyan TA, Jacobson S. Brain volume measurements in patients with human T-cell lymphotropic virus-1-associated tropical spastic paraparesis. J Neurovirol. 2006 Oct; 12(5):349-55. PMID: 17065127.
      View in: PubMed
    39. Gupta S, Solomon JM, Tasciyan TA, Cao MM, Stone RD, Ostuni JL, Ohayon JM, Muraro PA, Frank JA, Richert ND, McFarland HF, Bagnato F. Interferon-beta-1b effects on re-enhancing lesions in patients with multiple sclerosis. Mult Scler. 2005 Dec; 11(6):658-68. PMID: 16320725.
      View in: PubMed
    40. Bagnato F, Butman JA, Mora CA, Gupta S, Yamano Y, Tasciyan TA, Solomon JM, Santos WJ, Stone RD, McFarland HF, Jacobson S. Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis. J Neurovirol. 2005 Dec; 11(6):525-34. PMID: 16338746.
      View in: PubMed
    41. Bagnato F, Gupta S, Richert ND, Stone RD, Ohayon JM, Frank JA, McFarland HF. Effects of interferon beta-1b on black holes in multiple sclerosis over a 6-year period with monthly evaluations. Arch Neurol. 2005 Nov; 62(11):1684-8. PMID: 16157739.
      View in: PubMed
    42. Wingerter S, Gupta S, Le S, Shamasunder S, Bernstein R, Rabitaille W, Kukuyeva Y, Downie S. Unusual origin of the flexor digiti minimi brevis muscle. Clin Anat. 2003 Nov; 16(6):531-3. PMID: 14566903.
      View in: PubMed
    43. Dual-energy CT of pancreatic adenocarcinoma. Abdominal Radiology. 41:1317-1324.
    44. The scrotum. 843-873.
    45. Splenic lesions. 1111-1139.
    GUPTA's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description